MedTrace Logo

Effect of Intravenous Dexmedetomidine on Analgesic Duration of Infraclavicular Block

NCT01981369 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-05-29

No results posted yet for this study

Summary

The study will evaluate the effect of Dexmedetomidine sedation on the duration of infraclavicular block in patients scheduled for surgery of elbow, forearm and/or hand. All patients will receive infraclavicular block before the surgery and then they will be randomized to receive either Dexmedetomidine or Propofol sedation. Duration of the sensory block will be evaluated in recovery room, 24 and 48 hours after the surgery.

Hypothesis:

Primary: Dexmedetomidine sedation increases the duration of sensory infraclavicular block in patients scheduled for upper limb surgery.

Secondary: Dexmedetomidine sedation

* Gives an adequate level of sedation during the surgical procedure
* Reduces the requirements of postoperative opioids
* Improves the quality of sleep on the night of the surgery
* Increases patients satisfaction regarding the anesthesia technique
* Dexmedetomidine sedation is safe and easy to use
* Dexmedetomidine sedation provides less respiratory depression during the procedure.

Conditions

  • Postoperative Pain

Interventions

DRUG

Dexmedetomidine

Intravenous sedation with dexmedetomidine

DRUG

Propofol

Intravenous sedation with propofol

PROCEDURE

Infraclavicular block

All patients will receive ultrasound guided infraclavicular block with the standard protocol of the Block Room in St. Joseph Hospital.

Sponsors & Collaborators

  • London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

    lead OTHER

Principal Investigators

  • Shalini Dhir, MD, FRCPC · Lawson Health Research Institute & Western University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-07-31
Completion
2016-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01981369 on ClinicalTrials.gov